Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Magda Vigier"'
Autor:
Nathalie Cheron, Laurence Legros, Thierry Facon, Francois-Xavier Mahon, Michel Tulliez, Frederic Maloisel, Françoise Rigal-Huguet, Patrice Berthaud, François Guilhot, Philippe Rousselot, Agnès Buzyn, Christian Berthou, Magda Vigier, Mauricette Michallet, Martine Gardembas, Joëlle Guilhot
Publikováno v:
Blood. 102:4298-4305
In chronic myelogenous leukemia (CML) imatinib mesylate has been shown to selectively inhibit the tyrosine kinase domain of the oncogenic bcr-abl fusion protein. Using this agent alone high rates of cytogenetic responses were recorded. However, sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bb7bed9f560763ec5f08bca82be49c5
https://doi.org/10.1182/blood-2003-04-1010
https://doi.org/10.1182/blood-2003-04-1010
Autor:
Hervé Avet-Loiseau, Marie-Paule Mellerin, Jean-Luc Harousseau, Noel Milpied, Régis Bataille, Magda Vigier, Fanny Gaillard, Anne Moreau
Publikováno v:
ResearcherID
Comparative genomic hybridization (CGH) was used to analyse 34 follicular lymphoma (FL) samples. 27 samples showed DNA sequence copy number changes of at least one genomic region (26 samples with at least one gain and nine with at least one loss). So
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28af022759b353f66cc8cb2a2971fef0
https://doi.org/10.1046/j.1365-2141.1997.d01-2140.x
https://doi.org/10.1046/j.1365-2141.1997.d01-2140.x
Autor:
Vincent Delwail, Saïd Atmani, Mahmoud Dib, Marc Bernard, Josette Brière, C. Ghandour, Christine Le Maignan, Magda Vigier, Christian Berthou, Jean-Marie Andrieu, Hervé Maisonneuve, Bernard Desablens, Annick Le Mevel, Philippe Casassus, Catherine Traulle, Pierre Colonna
Publikováno v:
Blood. 103(1)
From 1990 to 1996, a total of 386 adult patients with early/intermediate Hodgkin disease (HD) were randomly assigned to receive 3 cycles of adriamycin, bleomycin, vinblastine, dacarbazine (an alkylating agent), and methylprednisolone (ABVDm, arm A) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8760fd7c43568c909d2dd7c636ad167a
https://pubmed.ncbi.nlm.nih.gov/12907440
https://pubmed.ncbi.nlm.nih.gov/12907440
Autor:
Michel Tulliez, François Guilhot, Agnès Buzyn, Joelle Guilhot, Philippe Rousselot, Laurence Legros, Françoise Rigal-Huguet, Albert Najman, Mauricette Michallet, Magda Vigier, Frédéric Maloisel, Patrice Berthaud, Francois-Xavier Mahon, Thierry Facon, Christian Berthou, Martine Gardembas
Publikováno v:
Seminars in hematology. 40(2 Suppl 2)
Imatinib (Gleevec) (formerly STI571) has been shown to selectively inhibit the tyrosine kinase domain of the oncogenic BCR-ABL fusion protein of chronic myelogenous leukemia (CML) cells. In recent phase I and II studies testing this new compound in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1acdf8a5a2e6b89e21d1962b23edbb0e
https://pubmed.ncbi.nlm.nih.gov/12783382
https://pubmed.ncbi.nlm.nih.gov/12783382
Autor:
M P Mellerin, Noel-Jean Milpied, J-L Harousseau, Nadine Morineau, Béatrice Mahé, Magda Vigier, Philippe Moreau
Publikováno v:
Bone marrow transplantation. 31(6)
This study was designed to evaluate the results of high-dose therapy followed by purged autologous stem cell transplantation (ASCT) for patients with low-grade follicular non Hodgkin's lymphoma (LGFL), and the prognostic significance of PCR detection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff591b67f5df483493e3fabc898c5efa
https://pubmed.ncbi.nlm.nih.gov/12665842
https://pubmed.ncbi.nlm.nih.gov/12665842
Autor:
Nadine Morineau, J-L Harousseau, Béatrice Mahé, Philippe Casassus, Noel-Jean Milpied, Pierre Colonna, Jean-Marie Andrieu, François Guilhot, A. Le Mevel, Jean Briere, Stephane Vigouroux, Philippe Moreau, M. J. Rapp, Francoise Mechinaud, Magda Vigier, JF Abgrall, Philippe Colombat, Bernard Desablens, Norbert Ifrah
Publikováno v:
Bone marrow transplantation. 29(10)
This retrospective study compares high-dose therapy (HDT) with autologous stem cell transplantation and combined-modality treatment (CT) as a first-line therapy for Hodgkin's disease (HD) for patients with both a clinical stage (CS) IV and/or a media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97236b1c860ec1992fc6f4b4fa78451a
https://pubmed.ncbi.nlm.nih.gov/12058233
https://pubmed.ncbi.nlm.nih.gov/12058233
Autor:
Thierry Lamy, Remy Gressin, Olivier Tournilhac, Sylvie Caulet Maugendre, Steven Le Gouill, David Assouline, Annie Le Mevel, Laurent Sutton, Philippe Rodon, Krimo Bouabdallah, Sophie Park, Bruno Lioure, Martine Gardembas, Charles Dauriac, Bruno Villemagne, Magda Vigier, Mario E Ojeda Uribe, Delphine Senecal, Abderrazak El Yamani, Christiane Mounier
Publikováno v:
Blood. 112:1575-1575
2791 Introduction: Elderly mantle cell lymphoma (MCL) patients (pts) do not benefit from dose-intensive chemotherapy upfront.1 The GOELAMS group recently demonstrated that a regimen comprising Vincristine/Adriamycine/Dexamethasone plus Chlorambucil (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7db5505deb985a33a5addd54a1b9e272
https://doi.org/10.1182/blood.v112.11.1575.1575
https://doi.org/10.1182/blood.v112.11.1575.1575